GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 86 filers reported holding GENERATION BIO CO in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10 | -33.3% | 2,769 | +4.0% | 0.00% | – |
| Q2 2023 | $15 | +25.0% | 2,662 | -1.5% | 0.00% | – |
| Q1 2023 | $12 | -88.2% | 2,702 | -89.6% | 0.00% | – |
| Q4 2022 | $102 | -99.9% | 26,037 | +0.0% | 0.00% | – |
| Q3 2022 | $138,000 | -18.8% | 26,033 | +0.4% | 0.00% | – |
| Q2 2022 | $170,000 | +33.9% | 25,917 | +50.1% | 0.00% | – |
| Q1 2022 | $127,000 | -43.0% | 17,268 | -45.1% | 0.00% | – |
| Q4 2021 | $223,000 | -71.8% | 31,468 | -0.4% | 0.00% | -100.0% |
| Q3 2021 | $792,000 | -24.9% | 31,610 | -19.4% | 0.00% | 0.0% |
| Q2 2021 | $1,055,000 | +66.9% | 39,227 | +76.7% | 0.00% | 0.0% |
| Q1 2021 | $632,000 | +98.7% | 22,200 | +98.2% | 0.00% | – |
| Q4 2020 | $318,000 | +83.8% | 11,200 | +100.0% | 0.00% | – |
| Q3 2020 | $173,000 | – | 5,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |